MedicarePartD.guide

A non-government resource built from CMS public data

Overactive bladder drugs on AARP Medicare Rx Saver from UHC (S5921-356)

Oxybutynin, solifenacin, Myrbetriq and Gemtesa, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Florida
Premium
$98.70/month
Deductible
$615.00
Change plan

3 of 7 Overactive bladder drugs are covered on this plan. 2 of them require prior authorization.

4 aren't on the formulary, including Myrbetriq and mirabegron.

  • oxybutynin
    generic Ditropan
    Covered · prior auth
    $8.00
    Tier 2
  • solifenacin
    generic Vesicare
    Covered · prior auth
    from $2.25
    Tier 4
  • Gemtesa
    vibegron
    Covered
    18%
    Tier 3
Not on the formulary
Myrbetriq, mirabegron, tolterodine, trospium

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list